default author photo

Lin Fa Wang

Duke-NUS Medical School - Programme in Emerging Infectious Diseases

SCHOLARLY PAPERS

9

DOWNLOADS

943

TOTAL CITATIONS

6

Scholarly Papers (9)

1.

Antibody Response of Heterologous vs Homologous mRNA Vaccine Boosters Against the SARS-CoV-2 Omicron Variant: Interim Results from the PRIBIVAC Study, A Randomized Clinical Trial

Number of pages: 35 Posted: 16 Mar 2022
National Centre for Infectious Diseases, Duke NUS Medical School, National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, University of Liverpool, University of Liverpool, Duke-NUS Medical School, National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), National Centre for Infectious Diseases (Singapore), Duke-NUS Medical School, University of Liverpool, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS), National Centre for Infectious Diseases (Singapore), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Duke-NUS Medical School - Programme in Emerging Infectious Diseases and National Centre for Infectious Diseases, Singapore
Downloads 207 (368,123)
Citation 5

Abstract:

Loading...

COVID-19 vaccine booster, humoral immunity, omicron, live virus neutralization

2.

Pathogen Genomic Surveillance in Asia: A Multi-Country Assessment

Number of pages: 28 Posted: 28 Jul 2023
National University of Singapore (NUS) - Programme in Health Services and Systems Research, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Duke-NUS Medical School, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Centre for Outbreak Preparedness, National University of Singapore (NUS) - Centre for Outbreak Preparedness, The SingHealth Duke-NUS Global Health Institute (SDGHI), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Duke-NUS Medical School, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, The SingHealth Duke-NUS Global Health Institute (SDGHI) and Independent
Downloads 154 (482,968)

Abstract:

Loading...

infectious disease surveillance, genomics, whole genome sequencing, high throughput sequencing, cross-sectional analysis, emergency preparedness, pandemic preparedness, outbreak preparedness, Asia, South Asia, Southeast Asia, ASEAN

3.

Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 th Dose Booster

Number of pages: 43 Posted: 29 Jun 2023
University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne, University of Melbourne - Departments of Medicine and Infectious Diseases at the Doherty Institute, University of Melbourne - Department of Microbiology and Immunology, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne, University of Melbourne, Flinders University, University of Melbourne, University of Melbourne, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Centre for Epidemiology and Biostatistics, University of Melbourne, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, SingHealth Duke-NUS Global Health Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), Flinders University, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Monash University - Monash Institute of Pharmaceutical Sciences, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Centre for Epidemiology and Biostatistics, Monash University - Monash Institute of Pharmaceutical Sciences and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 127 (569,079)

Abstract:

Loading...

SARS-CoV-2, vaccine, receptor binding domain, recombinant protein, mRNA, beta variant, phase I trial.

4.

Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59

Number of pages: 52 Posted: 26 Mar 2024
University of Melbourne - Department of Microbiology and Immunology (DMI), University of New South Wales (UNSW), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), La Trobe University - Department of Biochemistry & Chemistry, The Walter and Eliza Hall Institute of Medical Research, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Royal Melbourne Hospital, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI) and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 118 (604,538)

Abstract:

Loading...

SARS-CoV-2, COVID-19 variants, vaccine, virus-like particles, VLP, receptor-binding domain, RBD

5.

Diversity and Distinctive Traits of the Global RNA Virome in Urban Environments

Number of pages: 35 Posted: 24 Jun 2024
East China Normal University (ECNU) - Institute of Biomedical Sciences, East China Normal University (ECNU) - Institute of Biomedical Sciences, Cornell University - Weill Cornell Medicine, East China Normal University (ECNU) - Institute of Biomedical Sciences, Tongji University, Cornell University, Lund University, University of Duisburg-Essen, Barcelona Institute for Global Health (ISGlobal) - CLIMA Climate and Health Program, University of Tübingen - Institute of Tropical Medicine, CERTH - Chemical Process and Energy Resources Institute, Centre for Research and Technology Hellas (CERTH), Universidade do Porto, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, Elizade University, University of Copenhagen - Section for Ecology and Evolution, Cornell University - Weill Cornell Medicine, Indian Statistical Institute, New Delhi - Indian Statistical Institute, Universidad Andrés Bello, Cornell University - Weill Cornell Medicine, Cornell University - Department of Physiology and Biophysics, City University of New York (CUNY), University of Southern California, University of Southern California, University of Southern California, University of Science and Technology (Hong Kong), Jagiellonian University in Krakow, Jagiellonian University in Krakow, Medical University of Bialystok, Institute of Molecular Biology and Genetics NAS of Ukraine, University of Hawaii at Manoa - John A. Burns School of Medicine, University of Hawaii at Manoa - Department of Complementary and Integrative Medicine, University of Idaho, - School of Medicine, Universiti Kebangsaan Malaysia, Keio University, City University of Hong Kong (CityU), Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Weill Cornell Medicine - Department of Physiology, Biophysics, and Systems Biology and East China Normal University (ECNU) - Center for Bioinformatics and Computational Biology
Downloads 84 (777,583)

Abstract:

Loading...

RNA Virus, Urban environment, Metatranscriptomics, Phylogenetic diversity, Biogeographical pattern

6.

Longitudinal Analysis of Neutralizing Antibodies Against SARS-CoV-1 and Different SARS-CoV-2 Strains in Breakthrough and Unvaccinated Covid-19 Patients in Thailand

Number of pages: 39 Posted: 29 Jun 2024
Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies, Prachatipat Hospital, Prachatipat Hospital, Vichaivej International Hospital, Vichaivej International Hospital, Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Mahidol University - Mahidol-Oxford Tropical Medicine Research Unit, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University - Institute of Human Righs and Peace Studies and Mahidol University - Institute of Human Righs and Peace Studies
Downloads 76 (830,555)
Citation 1

Abstract:

Loading...

COVID-19, neutralizing antibody, SARS-CoV-1, SARS-CoV-2, variants, vaccination

7.

Contrasting SARS-CoV-2 Epidemics in Singapore: Cohort Studies in Migrant Workers and the General Population

Number of pages: 15 Posted: 15 Apr 2021
National University of Singapore (NUS) - Saw Swee Hock School of Public Health, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National University Health System, Alexandra Hospital - Infectious Diseases, Duke-NUS Medical School - Programme in Emerging Infectious Diseases and National University of Singapore (NUS) - Saw Swee Hock School of Public Health
Downloads 75 (837,727)

Abstract:

Loading...

8.

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional Analysis

Number of pages: 30 Posted: 07 Dec 2022
Monaco Directorate of Health Affairs, Aix-Marseille University - Aix Marseille Institute of Public Health ISSPAM, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, Centre Scientifique de Monaco, Centre Scientifique de Monaco, Centre Scientifique de Monaco, Centre Scientifique de Monaco, Monaco Directorate of Health Affairs, Government of the United Kingdom - Vaccines (Research and Development), GenScript Biotech, Duke-NUS Medical School - Programme in Emerging Infectious Diseases and Monaco Directorate of Health Affairs
Downloads 68 (891,180)

Abstract:

Loading...

SARS-CoV-2, neutralizing antibodies, vaccination, COVID-19, hybrid immunity

9.

Neutralising Antibody Levels and Risk of SARS-CoV-2 Infection: A Nationwide Open Cohort Study in Monaco

Number of pages: 30 Posted: 12 Mar 2026
Aix Marseille University - Institute of Public Health, Monaco Directorate of Health Affairs, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Monaco Directorate of Health Affairs, Centre Scientifique de Monaco, Centre Scientifique de Monaco, Centre Scientifique de Monaco, Monaco Department of Social Affairs and Health, Monaco Department of Social Affairs and Health, Aix-Marseille University - Aix Marseille Institute of Public Health ISSPAM and Monaco Directorate of Health Affairs
Downloads 34 (1,263,436)

Abstract:

Loading...

SARS-CoV-2, neutralising antibodies, vaccination, (hybrid) immunity, cohort